Categories LATEST

United Airlines to replace employee bonus with lotto

Courtesy : Wikimedia Commons

United Airlines is planning to do away with its quarterly performance bonuses for employees. The airline will replace the employee bonuses with a new program called ‘Core4 Score Rewards.’

The new rewards program is a lottery-style drawing with prizes that include cash, cars and vacation packages. There is also a $100,000 grand prize which will be awarded each quarter to one eligible employee.

This new program will benefit only a few people who win the lottery while the rest of the eligible employees will not receiving any rewards for their contributions.

The Core4 program was formed after the horrific passenger-dragging incident with an intention to boost United’s image as a caring airline. The new lottery plan, which is part of this program, was expected to create excitement and a sense of accomplishment.

However, the initial response to the announcement of the program has not been exciting at all. It has, in fact, led to a widespread discord among the employees of the airline. This lack of harmony and satisfaction is not likely to create a caring environment.

United Airlines said it would offer other incentives along with the lottery and that this new program will not have any impact on its profit-sharing program.

At a time when United Airlines is frequently in the news for unpleasant reasons, one wonders if this is indeed a wise step.

In a separate incident earlier, a United Airlines flight from Virginia to Washington experienced severe turbulence due to bad weather, which led to the entire flight ‘throwing up.’

All passengers aboard Flight 3833 suffered a rough landing after being hit by a powerful storm, and almost everyone including the crew threw up. Even the pilots came close to falling ill.

However, no one needed medical attention due to the incident.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top